Biotech

Illumina’s Michael Ball Joins Contextual Genomics as CEO

Cancer genomics company Contextual Genomics has appointed Michael Ball to serve as its CEO. Ball comes to the Vancouver, BC-based company from Illumina (NASDAQ: ILMN), where he was global vice president commercial, informatics. Ball was previously CEO of GenoLogics Life Sciences Software, which was acquired by Illumina in 2015. Contextual Genomics develops molecular tests that help clinicians diagnose and treat cancer.

UNDERWRITERS AND PARTNERS

          

          

            
https://xconomy.com/seattle/2019/03/15/illuminas-michael-ball-joins-contextual-genomics-as-ceo/

Advertisements
READ  Blocking brain inflammation in multiple sclerosis with gut immune cells

Categories: Biotech, Industry, Life Sciences, Seattle

Tagged as: ,

Leave a Reply